Publications by authors named "Janine Webb"

Claim this Profile
A
Avoiding piecemeal research on participation in cervical cancer screening: the advantages of a social identity framework.
Candice Tribe, Janine Webb

Health Expect· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial.
Alicia F C Okines, Sue E Ashley, David Cunningham, Jacqueline Oates, Andrea Turner, Janine Webb

J Clin Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.
Naureen Starling, David Watkins, David Cunningham, Janet Thomas, Janine Webb

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of acute nociceptive responses in rat spinal cord by a bradykinin B1 receptor antagonist.
Rachel K Conley, Alan Wheeldon, Janine K Webb, Robert M DiPardo, Carl F Homnick

Eur J Pharmacol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.
Guy R Seabrook, Kathy G Sutton, Wolfgang Jarolimek, Gregory J Hollingworth, Simon Teague, Janine Webb

J Pharmacol Exp Ther· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile.
Yves Leblanc, Patrick Roy, Zhaoyin Wang, Chun Sing Li, Nathalie Chauret, Janine Webb

Bioorg Med Chem Lett· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils.
Nadia M J Rupniak, Emma Carlson, Susan Boyce, Janine K Webb, Raymond G Hill

Pain· September 1996

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis